Maintenance Therapy with 3-monthly Bacillus Calmette-Guérin for 3 Years is Not Superior to Standard Induction Therapy in High-risk Non-muscle-invasive Urothelial Bladder Carcinoma: Final Results of Randomised CUETO Study 98013

European Urology

Volumn 68, Issue 2, 2015, Pages 256-262

  Martínez Piñeiro, Luis ^a   Portillo, José A ^b   Fernández, Jesús M ^c   Zabala, José A ^d   Cadierno, Iker ^d   Moyano, José L ^e   Solsona, Eduardo ^f   Unda, Miguel ^g   Beardo, Pastora ^h   Rodríguez Molina, Jesús ⁱ   Chantada, Venancio ^j   Palou, Joan ^k   Muntañola, Pedro ^l   Alonso Dorrego, José M ^m   Pérez Garcia, Franciso J ⁿ   Silva, Juan M ^o   Chesa, Nicolás ^p   Montesinos, Manuel ^q   Ojea, Antonio ^r   Madero, Rosario ^m   Martínez Piñeiro, José A ^s   more..

^a HOSPITAL UNIVERSITARIO INFANTA SOFÍA   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^d HOSPITAL DE CRUCES   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^f IVO   (Spain)

^g HOSPITAL DE BASURTO   (Spain)

^h HOSPITAL DE JEREZ   (Spain)

ⁱ HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^j HOSPITAL JUAN CANALEJO   (Spain)

^k FUNDACIÓ PUIGVERT   (Spain)

^l HOSPITAL ÁLVAREZ BUYLLA   (Spain)

^m HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

ⁿ HOSPITAL SAN AGUSTÍN   (Spain)

^o HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^p HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

^q Universidad Pública de Navarra   (Spain)

^r HOSPITAL XERAL CÍES   (Spain)

^s Clinica La Luz   (Spain)

more..

Author keywords

Bacillus Calmette Gu rin; Bladder cancer; Maintenance therapy

Indexed keywords

BCG VACCINE; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CONTROLLED STUDY; DISEASE FREE INTERVAL; DISEASE SPECIFIC SURVIVAL; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; DRUG WITHDRAWAL; DYSURIA; FEMALE; HEMATURIA; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALAISE; MALE; NON MUSCLE INVASIVE BLADDER CANCER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VERY ELDERLY; AMBULATORY CARE; CARCINOMA; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COMPARATIVE STUDY; DISEASE COURSE; DISEASE FREE SURVIVAL; DRUG ADMINISTRATION; DRUG EFFECTS; INDUCTION CHEMOTHERAPY; INTRAVESICAL DRUG ADMINISTRATION; KAPLAN MEIER METHOD; MAINTENANCE CHEMOTHERAPY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PATHOLOGY; RISK FACTOR; SPAIN; TIME; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS; UROTHELIUM;

ADMINISTRATION, INTRAVESICAL; ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANTINEOPLASTIC AGENTS; BCG VACCINE; CARCINOMA; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INDUCTION CHEMOTHERAPY; KAPLAN-MEIER ESTIMATE; MAINTENANCE CHEMOTHERAPY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; SPAIN; TIME FACTORS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84937521687     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2015.02.040     Document Type: Article

References (14)

1. J. Fernandez-Gomez, R. Madero, E. Solsona, and et al. Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model J Urol 182 2009 2195 2203
2. M. Babjuk, M. Burger, R. Zigeuner, and et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013 Eur Urol 64 2013 639 653
3. A. Bohle, D. Jocham, and P.R. Bock Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity J Urol 169 2003 90 95
4. R.J. Sylvester, M.A. van der, and D.L. Lamm Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials J Urol 168 2002 1964 1970
5. D.L. Lamm, B.A. Blumenstein, J.D. Crissman, and et al. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study J Urol 163 2000 1124 1129
6. J. Oddens, M. Brausi, R. Sylvester, and et al. Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guerin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance Eur Urol 63 2013 462 472
7. World Medical Association Declaration of Helsinki Recommendations guiding physicians in biomedical research involving human subjects JAMA 277 1997 925 926
8. National Cancer Institute. Common toxicity criteria (CTC) v2.0; 1999.
9. J.A. Martinez-Pineiro, L. Martinez-Pineiro, E. Solsona, and et al. Has a 3-fold decreased dose of bacillus Calmette-Guerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of a prospective randomized trial J Urol 174 2005 1242 1247
10. A. Böhle, J. Gerdes, A.J. Ulmer, A.G. Hofstetter, and H.D. Flad Effects of local bacillus Calmette-Guerin therapy in patients with bladder carcinoma on immunocompetent cells of the bladder wall J Urol 144 1990 53 58
11. A. Böhle, C. Nowc, A.J. Ulmer, and et al. Elevations of cytokines interleukin-1, interleukin-2 and tumor necrosis factor in the urine of patients after intravesical bacillus Calmette-Guerin immunotherapy J Urol 144 1990 59 64
12. M. Brausi, L. Collette, K. Kurth, and et al. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies Eur Urol 41 2002 523 531
13. J.P. Sfakianos, P.H. Kim, A.A. Hakimi, and H.W. Herr The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Guerin J Urol 191 2014 341 345
14. M.O. Grimm, C. Steinhoff, X. Simon, P. Spiegelhalder, R. Ackermann, and T.A. Vogeli Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study J Urol 170 2003 433 437